Related Experiment Video

Updated: Jan 31, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K

Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC

Roser Pinyol1, Daniela Sia2, Josep M Llovet3,2,4

  • 1Translational Research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Catalonia, Spain.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 9, 2019
PubMed

Insights

Wnt/CTNNB1 mutations in hepatocellular carcinoma (HCC) are linked to immune-excluded tumors. These mutations may predict resistance to immune checkpoint inhibitors, requiring further validation for personalized immunotherapy.

Area of Science:

  • Oncology
  • Immunotherapy
  • Genomics

Background:

  • Next-generation sequencing (NGS) identifies actionable targets and response biomarkers in cancer.
  • Hepatocellular carcinoma (HCC) is a major global health concern.
  • Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment.

Purpose of the Study:

  • To investigate the role of Wnt/CTNNB1 mutations in HCC.
  • To determine if these mutations are biomarkers for ICI resistance.
  • To validate findings for personalized immunotherapy in advanced HCC.

Main Methods:

  • Genomic analysis using next-generation sequencing.
  • Tumor immune profiling.
  • Correlation analysis between mutations and treatment response.

Main Results:

  • Wnt/CTNNB1 mutations define an immune-excluded (cold tumor) phenotype in HCC.
  • These mutations are potential biomarkers predicting resistance to immune checkpoint inhibitors.

Conclusions:

  • Wnt/CTNNB1 mutations are associated with specific tumor immune microenvironments in HCC.
  • Further large-scale validation is necessary to guide immunotherapy customization in advanced HCC.

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.8K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.9K

Related Concept Videos

The Pauli Exclusion Principle03:06

The Pauli Exclusion Principle

The arrangement of electrons in the orbitals of an atom is called its electron configuration. We describe an electron configuration with a symbol that contains three pieces of information:
59.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
What is the Immune System?01:38

What is the Immune System?

Overview
127.8K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.4K